American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead: Benzodiazepine Discontinuation and Mortality

Lead: Benzodiazepine Discontinuation and Mortality

Tuesday 9th January 2024

Uncover the risks of benzodiazepine discontinuation and explore new therapies and trends in addiction medicine in this episode.
5 minutes
Informative
Educational
Supportive
Empowering
Inspiring

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Benzodiazepine Discontinuation: Risks and Revelations in Addiction Medicine

Episode Overview

  • The study on benzodiazepine discontinuation reveals potential harms associated with the cessation of long-term therapy.
  • Insights into neuromodulation therapies shed light on their effectiveness in reducing substance use and craving.
  • The episode provides valuable information on the risks of developing substance use disorder associated with different substances.
  • Exploration of the impact of ketamine on anterior cingulate resting state function connectivity in depressed individuals.
  • Trends in teen drug use and the associated impact on overdose deaths are discussed, offering valuable insights.
Our lead story this week in JAMA Network Open is titled Benzodiazepine Discontinuation and Mortality Among Patients Receiving Long-Term Benzodiazepine Therapy.
Ever wondered about the potential risks of stopping long-term benzodiazepine use? This episode of 'Addiction Medicine Unpacked' takes you through the latest findings on this critical topic. Hosted by Claire Rasmussen, the episode dives into a comparative study involving over 350,000 patients, revealing that discontinuing benzodiazepines can lead to increased mortality and other serious harms like nonfatal overdoses and suicidal thoughts. It's a must-listen for anyone concerned with the complexities of addiction treatment. But that's not all.
The episode also explores groundbreaking neuromodulation therapies for substance use disorders and delves into the intriguing effects of ketamine on those battling treatment-resistant depression. Curious about how different substances contribute to the risk of developing a substance use disorder? Or perhaps you're interested in the latest trends in teen drug use? This episode covers it all. Whether you're a healthcare professional, a student, or someone personally affected by addiction, you'll find a wealth of valuable information here.
The discussions are not just about presenting data; they offer real-world applications and insights that could potentially save lives. Tune in to get a comprehensive view of the latest developments in addiction medicine.